glp-1 agonist and pancreatitis New data links agonists for weight loss with higher risk for pancreatitis, GI events What Are GLP-1 Agonists For
Description
Machineni, S
doi: 10.7334/psicothema2015.244
Diabetes Care 41 , 258266 (2017)
For research professionals, the practical implications are clear
Current evidence suggests that most cases of hair loss associated with GLP-1 medications are related to rapid weight loss, nutritional changes, and metabolic stress , rather than a direct drug effect
No acute effects of exogenous glucose-dependent insulinotropic polypeptide on energy intake, appetite, or energy expenditure when added to treatment with a long-acting glucagon-like peptide 1 receptor agonist in men with type 2 diabetes
